About this trial
This randomized clinical trial aims to evaluate and compare the analgesic efficacy of the Serratus Posterior Superior Intercostal Plane (SPSIP) block and the Erector Spinae Plane (ESP) block in patients undergoing surgical stabilization of rib fractures. The primary outcome is the Visual Analog Scale (VAS) score within the first 24 hours after surgery. Secondary outcomes include total opioid consumption, requirement for rescue analgesia, block performance time, block-related and systemic side effects (hematoma, pneumothorax, local anesthetic systemic toxicity, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and quality of recovery assessed using the QoR-15 questionnaire.
Eligibility criteria
Qualifiers
Patients aged 18-65 years
ASA physical status I-III
Scheduled for elective video-assisted thoracoscopic surgery
Body mass index (BMI) between 18 and 35 kg/m²
Disqualifiers
Refusal to participate
Allergy to local anesthetics
Infection at the injection site
Coagulopathy or ongoing anticoagulant therapy
Trial design
Treatments tested in this trial
- Erector Spinae Plane Block (ESP)
- Serratus Posterior Superior Intercostal Plane (SPSIP)